Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Theseus Pharmaceuticals Inc.
Headquarters: Cambridge, MA, United States of America
Website: N/A
Year Founded: 2017
Status: Acquired
BioCentury | Feb 25, 2025
Deals
Counteroffer from Tang-backed Concentra could scuttle Acelyrin-Alumis: Deals Report
Plus Radiance gets ROR1 ADC from Cspc, Astrazeneca buys Fibrogen’s China subsidiary and more
BioCentury | Jan 13, 2025
Deals
Quick exit for Idrx shareholders as GSK pays $1B to get GIST asset
Early clinical data show efficacy signals that appear to improve on existing therapies in GI cancer settings
BioCentury | Jun 26, 2024
Management Tracks
Arvinas, Frontier name new CFOs
Plus: Audrey Duval to lead corporate affairs at Sanofi, and updates from MOMA,
BioCentury | Mar 27, 2024
Management Tracks
Furuta to become CFO at Takeda
Plus: IDRx names Kerstein CMO and updates from Transgene, Noetik, Egle and MannKind
BioCentury | Mar 13, 2024
Management Tracks
IDRx names Clackson, Dahms to C-suite and Auspitz chair
Plus: new COO for radiopharma
BioCentury | Dec 5, 2023
Management Tracks
Glucksmann at the helm at Sensorium
Plus: CEO, CMO out at Theseus and updates from Zenas, Nanoscope, Immunitas and more
BioCentury | Jul 15, 2023
Deals
July 14 Quick Takes: Korro heads to NASDAQ via reverse merger
Plus: Theseus abandons GIST therapy, Roche-Roivant rumors
BioCentury | Dec 18, 2021
Management Tracks
Tong Zhang joins Jing Li at VelaVigo
Plus: Coherus, Allen Institute, Transcenta
BioCentury | Dec 17, 2021
Finance
Omega to stress company creation with largest fund
Omega Funds closes oversubscribed seventh fund at $650M
BioCentury | Oct 8, 2021
Finance
Nearing $30B in 2021, global biotech IPOs on pace to top record
IPOs by Pyxis, IsoPlexis and Cognition bring October’s tally to almost $900M in fresh paper
Items per page:
1 - 10 of 16